Prelude Capital Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-484
Closed -$46K 1524
2020
Q3
$46K Hold
484
﹤0.01% 1145
2020
Q2
$44K Buy
+484
New +$41.5K ﹤0.01% 1193
2020
Q1
Sell
-1,078
Closed -$91K 1622
2019
Q4
$91K Hold
1,078
﹤0.01% 1145
2019
Q3
$80K Hold
1,078
﹤0.01% 1026
2019
Q2
$83K Hold
1,078
﹤0.01% 1000
2019
Q1
$82K Hold
1,078
﹤0.01% 988
2018
Q4
$74K Buy
1,078
+265
+33% +$20.1K 0.01% 1011
2018
Q3
$69K Buy
813
+194
+31% +$15.5K ﹤0.01% 1052
2018
Q2
$46K Buy
619
+234
+61% +$16.9K ﹤0.01% 1139
2018
Q1
$27K Buy
385
+128
+50% +$9.23K ﹤0.01% 1223
2017
Q4
$18K Buy
257
+64
+33% +$4.37K ﹤0.01% 1152
2017
Q3
$13K Hold
193
﹤0.01% 1398
2017
Q2
$13K Buy
+193
New +$12.4K ﹤0.01% 1348

Other funds holding FXH

Prelude Capital Management's FXH Position: Q4 2020 in Review

Prelude Capital Management sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2020, closing a stake of 484 shares — an estimated $46K sold.

Prelude Capital Management first reported a position in FXH in Q2 2017 and held it in 13 quarters. The position peaked at $91K in Q4 2019. 226 funds tracked by Wall St. Rank hold FXH as of Q4 2020.

  • Prelude Capital Management reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 484 First Trust Health Care AlphaDEX Fund shares in Q4 2020, an estimated $46K.
  • Prelude Capital Management first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2017 and held it in 13 quarters.
  • Prelude Capital Management's First Trust Health Care AlphaDEX Fund position peaked at $91K in Q4 2019.
  • 226 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.